Published in Surgery Litigation and Law Weekly, May 11th, 2007
Symbion's Board of Directors approved the transaction following the unanimous recommendation of a Special Committee of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.